miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer
Clinical and Translational Oncology Sep 16, 2017
Kang M, et al. - Experts explored down- and upregulated miRNAs and mRNA which could be used as potential biomarkers and/or therapeutic targets for lung cancer. In finding the novel target in cancer research, the data mining based on online databases was an effective method. They noticed important role paled by miR-33a and cullin-associated NEDD8-dissociated protein 1 (CAND1) in lung cancer proliferation and cell migration.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries